Transdermal Patch: Clinical Trials

22 trials of Transdermal Patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 unknown, 2 recruiting, 1 terminated. 22 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 322Completed 15, Unknown 4, Recruiting 2, Terminated 1
Phase 24Completed 4

Follow Transdermal Patch: new trials by email Literature Review of Transdermal Patch trials Research Report on Transdermal Patch

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1 of 3)
Combination Nicotine Replacement Therapy (patch and lozenge) - Remote vs. In-Person, Remote Visits
Phase 2 / Phase 3CompletedState University of New York at Buffalo2002025-03-102026-10-21
Effectiveness of Different THR Products in Adult Population
E-Cigarette, Nicotine patch - Smoking Cessation
Phase 3UnknownFoundation for a Smoke Free World INC2582024-06-012023-11-21
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Capsaicin 8% patch, Hydrocolloid dressing - Neuropathic Pain, Chronic Pain
Phase 3RecruitingUniversity Hospital, Brest462024-03-052026-06-15
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Capsaicin 179 Mg Cutaneous Patch, Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2) - Coccyx Disorder, Neuropathic Pain
Phase 3RecruitingNantes University Hospital1882023-11-082026-10-09
Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial)
Transdermal glyceryl trinitrate 10mg patches, Placebo patches - Radial Artery Spasm
Phase 3Unknown424 General Military Hospital1502021-01-012021-02-23
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2
Phase 3CompletedAssistance Publique - Hôpitaux de Paris322020-12-092022-02-11
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients
Patch, Nicotine, Patch, Placebo - Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2202020-11-062021-06-22
Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain
Lidocaine 5% patch, Placebo patch - Postoperative Pain, Lidocaine
Phase 3UnknownBeijing Tiantan Hospital1802020-10-152020-10-20
Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
Scopolamine Transdermal Patch [Transderm Scop], Scopolamine, Placebo Patch - Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness
Phase 3UnknownNaval Aeromedical Research Unit, Dayton3202019-04-012019-04-19
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
Low Dose Asenapine maleate transdermal patch, High Dose Asenapine maleate transdermal patch, Placebo - Schizophrenia
Phase 3CompletedNoven Pharmaceuticals, Inc.6172016-08-012020-10-22
Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma
Transdermal Patch, Loxoprofen sodium, Placebo (for loxoprofen sodium) - Trauma, Pain
Phase 3CompletedDaiichi Sankyo Brasil Farmacêutica LTDA2422015-10-012017-02-14
Capsaicin Patches In Knee Osteoarthritis In Obese Patients
capsaicin 8% patches (Qutenza), Placebo patches - Pain
Phase 3TerminatedNadine ATTAL222015-07-012019-04-17
Web-based Smoking Cessation Program for Tribal College Students
Internet-All Nations Breath of Life (I-ANBL), Honoring the Gift of Heart Health, Nicotine gum, Patch, or Lozenge or Zyban® or Chantix® - Smoking Cessation
Phase 3CompletedWon Choi, PhD, MPH2512015-05-012021-12-07
Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions
MySkin patch, Gauze and Patch - Wounds and Injuries, Abrasion
Phase 3CompletedAssociazione Infermieristica per lo studio delle Lesioni Cutanee1802012-04-012014-01-13
Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System
AG200-15 (cycles 1-13), Lessina crossover to AG200-15 - Contraception
Phase 3CompletedAgile Therapeutics15042010-08-012018-07-03
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
Skin biopsy, Lidocaine 5% patches - Diabetic Peripheral Neuropathy
Phase 2 / Phase 3CompletedAlbany Medical College512009-10-012020-06-11
HKT-500 in the Treatment of Adult Patients With Ankle Sprain
Ketoprofen Patch, Placebo Patch - Ankle Sprain
Phase 3CompletedHisamitsu Pharmaceutical Co., Inc.2402009-07-012015-06-04
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
rivastigmine, placebo - Parkinson's Disease, Apathy
Phase 3CompletedUniversity Hospital, Lille402009-03-012012-04-24
A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
Fentanyl 1-day transdermal patch (Titration Phase), Fentanyl 1-day transdermal patch (Double Blind Phase), Fentanyl 3-day transdermal patch (Double Blind Phase) - Pain, Cancer
Phase 2 / Phase 3CompletedJanssen Pharmaceutical K.K.1562007-12-012013-06-13
Non-Nicotine Agents for Smoking Cessation
bupropion and transdermal patch, transdermal patch and nicotine inhaler - Tobacco Use Disorder
Phase 3CompletedUS Department of Veterans Affairs2003-10-012008-04-04

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Pain (3)  ·  Smoking Cessation (3)  ·  COVID-19 (2)  ·  Neuralgia (2)  ·  Wounds and Injuries (2)  ·  Amblyopia (1)  ·  Anisometropia (1)  ·  Ankle Injuries (1)  ·  Chronic Pain (1)  ·  Hypogonadism (1)  ·  Lethargy (1)  ·  Motion Sickness (1)  ·  Neoplasms (1)  ·  Obesity (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  424 General Military Hospital (1)  ·  Agile Therapeutics (1)  ·  Albany Medical College (1)  ·  Associazione Infermieristica per lo studio delle Lesioni Cutanee (1)  ·  Beijing Tiantan Hospital (1)  ·  Daiichi Sankyo Brasil Farmacêutica LTDA (1)  ·  Foundation for a Smoke Free World INC (1)  ·  Hisamitsu Pharmaceutical Co., Inc. (1)  ·  Janssen Pharmaceutical K.K. (1)  ·  Nadine ATTAL (1)  ·  Nantes University Hospital (1)  ·  National Eye Institute (NEI) (1)  ·  Naval Aeromedical Research Unit, Dayton (1)  ·  Noven Pharmaceuticals, Inc. (1)

Countries

United States (10)  ·  France (6)  ·  Brazil (1)  ·  China (1)  ·  Greece (1)  ·  Italy (1)  ·  Japan (1)  ·  Pakistan (1)

Top investigators

Claire Carette (1)  ·  David Devos, MD, PhD (1)  ·  Elizabeth Garner, MD, MPH (1)  ·  Fang Luo, MD (1)  ·  George Harb, MD, MPH (1)  ·  Madeeha Malik, PhD (1)  ·  Tommaso Bianchi (1)  ·  William Bauman, MD (1)  ·  Won Choi, PhD, MPH (1)

Results publications

PMID 10319217, PMID 10376632, PMID 10623981, PMID 15851777, PMID 17349504, PMID 21252493, PMID 21717386, PMID 2205779, PMID 23343764, PMID 24218528, PMID 24402597, PMID 24968251, PMID 25582984, PMID 25586864, PMID 33326711, PMID 3344884, PMID 3461421, PMID 35676335, PMID 35687858, PMID 36609046, PMID 3674268, PMID 39691748, PMID 7609956

NIH funding

2008 (1), R01CA174481 (1), UH3TR004797 (1)